drugset / Trial / NCT03998709
Effect of Fasting Free Fatty Acids and Fasting Glucose on 1st and 2nd Phase Insulin Secretion
Phase 4
Withdrawn
Mayo Clinic
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · collab
Non-randomizedParallel-groupOpen-labelBasic science
Summary
Researchers are trying to determine how changes in fasting glucose and free fatty acids (products released from fat) affect insulin secretion.
Timeline
- Start
- 2020-02-01
- Primary completion
- 2021-12-31
- Completion
- 2022-07-31
Outcome
Outcome not reported
Stopped: “results from other study suggest no good reason to proceed”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Insulin | Protein / enzyme biologic | — | — |
| Background | Somatostatin | Traditional medicine (herbal / TCM) | — | — |
Indications
No indication recorded.